ArticleScientific reports2020

Significance of inflammatory indexes in atezolizumab monotherapy outcomes in previously treated non-small-cell lung cancer patients.

Yuki Katayama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.